Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study.
about
Health-related quality of life in patients with primary immunodeficiency diseaseDisease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, MexicoII Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis.High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies.What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic ReviewAssessment of renal function in patients with myositis and treated with subcutaneous immunoglobulin: a series of 24 casesDiscovering aspects of health-experiences of a web-based health diary among adults with primary immunodeficiency
P2860
Q26784167-1F822B64-96A3-41BB-B86E-37C26FF12E7EQ33610367-D3922E8D-0DC7-4C93-960D-E58573C6F04BQ33692418-9B513F33-E222-4517-B677-3B961F899279Q37031111-C26EF262-9C91-425A-ABC7-434E50C4137CQ38661420-4EBD967B-7CDF-4AA2-997B-6144CA81DF96Q38744512-C2A6CC88-B7A1-4EB4-9C65-65B5C931B701Q39604919-DD202524-298E-49CF-BC7B-7B6458A70C62Q48302996-7DFF2493-C30F-4187-AA90-E81D698E0022Q55311044-16F84D13-0ADD-4AB7-900A-943D98C2FCC1Q57177417-C1A318E7-4774-4534-B180-A89B05556AE4Q57482179-13826255-06DF-407A-8F7E-44555DA304A2Q58568480-AEA1450B-9080-459A-807F-A1F3F89CC714
P2860
Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@ast
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@en
type
label
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@ast
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@en
prefLabel
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@ast
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@en
P2093
P2860
P1476
Subcutaneous immunoglobulin re ...... prospective multicenter study.
@en
P2093
Alessandra Vultaggio
Andrea Matucci
Annarosa Soresina
Antonino Trizzino
Cinzia Milito
Claudia Toppino
Giuseppe Spadaro
Martire Baldassarre
Roberto Paganelli
Viviana Moschese
P2860
P304
P356
10.1007/S40261-015-0270-1
P577
2015-03-01T00:00:00Z